ID
int64
1
9.11k
age
float64
18
102
death
int64
0
1
sex
stringclasses
2 values
hospdead
int64
0
1
slos
int64
3
343
d.time
int64
3
2.03k
dzgroup
stringclasses
8 values
dzclass
stringclasses
4 values
num.co
int64
0
9
edu
float64
0
31
income
stringclasses
4 values
scoma
float64
0
100
charges
float64
1.17k
1.44M
totcst
float64
0
633k
totmcst
float64
-102.72
711k
avtisst
float64
1
83
race
stringclasses
5 values
sps
float64
0.2
99.2
aps
float64
0
143
surv2m
float64
0
0.97
surv6m
float64
0
0.95
hday
int64
1
148
diabetes
int64
0
1
dementia
int64
0
1
ca
stringclasses
3 values
prg2m
float64
0
1
prg6m
float64
0
1
dnr
stringclasses
3 values
dnrday
float64
-88
285
meanbp
float64
0
195
wblc
float64
0
200
hrt
float64
0
300
resp
float64
0
90
temp
float64
31.7
41.7
pafi
float64
12
890
alb
float64
0.4
29
bili
float64
0.1
63
crea
float64
0.1
21.5
sod
float64
110
181
ph
float64
6.83
7.77
glucose
float64
0
1.09k
bun
float64
1
300
urine
float64
0
9k
adlp
float64
0
7
adls
float64
0
7
sfdm2
stringclasses
5 values
adlsc
float64
0
7.07
8,101
71.461
0
male
0
10
1,655
ARF/MOSF w/Sepsis
ARF/MOSF
0
8
under $11k
0
13,818
9,869.6172
8,757.28906
14.5
white
22.796875
25
0.802979
0.736938
1
0
0
no
0.95
0.9
no dnr
10
73
8.699219
60
24
36.29688
128.5625
4.399414
1.799805
1.199951
139
7.469727
null
null
null
0
2
no(M2 and SIP pres)
2
8,102
70.15997
1
male
1
3
3
Cirrhosis
COPD/CHF/Cirrhosis
1
null
null
55
3,284
2,367.4102
2,257.75
16
white
18.898438
26
0.525879
0.326965
1
0
0
no
null
null
no dnr
3
113
10.298828
109
26
38.29688
414.8125
null
null
1.099854
147
7.489258
null
null
null
null
null
<2 mo. follow-up
2.446777
8,103
83.33496
1
male
0
200
226
Coma
Coma
2
17
$11-$25k
26
344,708
266,838.25
247,714
33
white
29.796875
43
0.079987
0.044998
12
0
0
yes
null
null
dnr after sadm
103
103
31.796875
118
38
39.19531
143.3125
null
null
1.399902
144
7.429688
null
null
null
null
0
adl>=4 (>=5 if sur)
0
8,104
65.23499
1
male
0
24
26
COPD
COPD/CHF/Cirrhosis
2
12
$11-$25k
0
14,680
11,844.125
10,716.4297
9
white
19.398438
41
0.869995
0.784912
1
0
0
no
null
null
dnr after sadm
1
82
16.597656
126
26
36.09375
196
4.899414
0.5
0.899902
134
7.439453
null
null
null
3
4
<2 mo. follow-up
4
8,105
68.74695
1
male
0
17
19
Coma
Coma
1
6
under $11k
55
13,519
10,571.8984
8,644.44531
13.333328
white
18.5
35
0.555908
0.487
1
1
0
no
0.25
0.2
dnr after sadm
1
131
12.798828
71
24
39
null
5.099609
0.599976
2
136
null
null
null
null
null
0
<2 mo. follow-up
0
8,106
67.67694
1
female
0
91
112
ARF/MOSF w/Sepsis
ARF/MOSF
1
12
$11-$25k
0
259,766
208,491.375
194,043.875
22.75
white
28.699219
36
0.613892
0.507935
52
1
0
no
0.3
0.05
dnr after sadm
38
63
10.5
124
10
36.29688
440
null
null
1.599854
126
7.519531
null
null
null
null
0
no(M2 and SIP pres)
0
8,107
72.68195
1
male
0
5
666
CHF
COPD/CHF/Cirrhosis
6
12
under $11k
0
2,763
2,216.8535
1,728.75977
10
white
21.199219
35
0.823975
0.712891
1
0
0
no
0.8
0.7
dnr after sadm
1
62
7.799805
74
32
36.09375
357.125
null
0.599976
1.799805
131
7.399414
null
null
null
0
null
no(M2 and SIP pres)
0.4948
8,108
71.15094
1
male
0
4
425
CHF
COPD/CHF/Cirrhosis
4
12
$11-$25k
0
2,546
2,086.7031
1,616.51953
17
white
29.796875
45
0.684937
0.517944
1
0
1
no
0.8
0.5
no dnr
4
107
7.599609
96
36
35.79688
370
3.399902
0.399963
3.799805
129
7.519531
null
null
null
1
0
no(M2 and SIP pres)
0
8,109
80.98297
1
male
0
14
151
COPD
COPD/CHF/Cirrhosis
3
9
under $11k
0
8,698
7,073.2539
6,178.77734
21
white
18.199219
32
0.803955
0.682983
1
0
0
no
null
null
no dnr
14
98
10.798828
73
40
35.79688
274.0625
4
1
1.5
136
7.369141
null
null
null
3
null
null
2.511099
8,110
70.79297
1
male
0
3
386
Lung Cancer
Cancer
1
6
null
0
2,528
1,650.9307
1,010.27979
14
white
13.898438
16
0.75293
0.495972
1
0
0
metastatic
0.5
0.1
no dnr
3
103
4.699219
101
18
36.09375
null
3.799805
0.399963
0.899902
137
null
null
null
null
null
null
null
1.940186
8,111
42.50497
1
male
0
7
20
Lung Cancer
Cancer
2
12
$25-$50k
0
5,223
3,816.0859
2,861.12891
15
white
31.199219
45
0.414978
0.112991
1
1
0
metastatic
null
null
dnr after sadm
1
107
24.398438
140
28
36.09375
214.28125
3
0.599976
0.899902
135
7.489258
null
null
null
2
3
<2 mo. follow-up
3
8,112
75.06897
0
male
0
3
1,641
CHF
COPD/CHF/Cirrhosis
2
10
null
0
1,650
1,356.8184
1,012.84961
19
white
20.898438
33
0.81897
0.704956
1
0
0
no
null
null
dnr after sadm
1
107
9.298828
60
24
35.69531
304.75
3.899902
1.099854
2.699707
141
7.479492
null
null
null
null
null
null
2.020996
8,113
66.30298
1
female
1
68
68
ARF/MOSF w/Sepsis
ARF/MOSF
4
13
under $11k
100
211,130
158,519.25
138,657.875
31.25
white
22
32
0.32196
0.207977
30
1
0
no
0.7
0.5
dnr after sadm
68
67
12.298828
104
10
38.29688
310
null
null
2.399902
139
7.399414
null
null
null
null
1
adl>=4 (>=5 if sur)
1
8,114
64.91394
1
male
0
6
1,312
COPD
COPD/CHF/Cirrhosis
4
8
under $11k
0
3,954
3,177.4356
3,081.94922
10
white
17.097656
40
0.890991
0.817993
1
0
0
no
0.5
0.4
dnr after sadm
2
119
13.398438
69
30
37.89844
155.53125
4.099609
0.299988
1.5
139
7.329102
null
null
null
null
1
null
1
8,115
76.06598
0
female
0
25
1,639
Coma
Coma
0
8
null
61
23,227
17,351.5156
15,446.7266
21.25
white
23.296875
41
0.312988
0.240997
1
0
0
no
0.3
0.2
dnr after sadm
1
114
12.298828
75
32
39.09375
151.40625
4.599609
0.5
0.799927
131
7.339844
null
null
null
null
0
no(M2 and SIP pres)
0
8,116
84.50098
1
male
0
6
833
CHF
COPD/CHF/Cirrhosis
3
11
null
0
3,319
2,655.6875
2,375.48828
4
white
14.798828
23
0.860962
0.769897
1
0
0
no
0.9
0.8
no dnr
6
105
13.099609
69
20
36.19531
344.4375
3.699707
0.199982
0.899902
141
7.479492
null
null
null
1
null
null
1.1669
8,117
62.35498
1
male
0
27
41
COPD
COPD/CHF/Cirrhosis
2
12
under $11k
0
57,132
47,951.4062
49,411.9062
28.75
white
32.195313
40
0.678955
0.508911
2
0
0
no
0.5
0.5
dnr after sadm
20
52
6.399414
148
31
36.39844
210
null
null
0.599976
130
7.369141
null
null
null
null
2
<2 mo. follow-up
2
8,118
71.07196
0
male
0
41
1,631
ARF/MOSF w/Sepsis
ARF/MOSF
3
null
null
0
54,979
41,784.8125
35,870.5625
34.25
white
28.097656
51
0.652954
0.553955
1
1
0
yes
0.25
0.0156
no dnr
41
57
15.699219
102
12
38.09375
178
2.5
1.799805
2.699707
139
7.339844
null
null
null
null
6
no(M2 and SIP pres)
6
8,119
50.51599
0
female
0
6
1,633
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
5,910
4,305.207
3,984.17969
20
white
20.398438
31
0.885986
0.845947
1
0
0
no
0.9
0.9
no dnr
6
74
19.699219
110
24
36.59375
261.875
3.299805
0.5
1.399902
139
7.429688
null
null
null
5
4
adl>=4 (>=5 if sur)
4
8,120
79.99695
1
male
0
30
32
ARF/MOSF w/Sepsis
ARF/MOSF
1
17
null
0
65,864
41,325.25
66,365
38.75
white
27
24
0.659912
0.56189
3
0
0
no
0.35
0.35
dnr after sadm
18
140
12.199219
138
15
38.59375
224.4375
null
null
0.799927
125
7.439453
null
null
null
null
0
<2 mo. follow-up
0
8,121
56.99399
1
male
1
24
24
Lung Cancer
Cancer
1
12
>$50k
0
2,625
34,046.4062
32,203.25
24.333328
white
16.898438
20
0.727905
0.455994
1
0
0
metastatic
0.5
0.25
dnr after sadm
7
51
5.199219
74
24
36.69531
null
3.699707
0.299988
0.899902
136
null
null
null
null
null
4
<2 mo. follow-up
4
8,122
70.09399
1
male
0
8
1,388
CHF
COPD/CHF/Cirrhosis
4
8
null
0
6,099
5,066.2188
4,108.25781
11.5
white
11.199219
26
0.921997
0.866943
1
1
0
no
0.95
0.9
no dnr
8
80
10.798828
77
20
36.39844
309.5
4.399414
0.399963
1.599854
139
7.439453
null
null
null
0
null
no(M2 and SIP pres)
0.4948
8,123
84.30396
1
male
0
22
29
ARF/MOSF w/Sepsis
ARF/MOSF
3
8
under $11k
9
29,884
21,718.8906
18,873.1875
20
white
27.699219
36
0.566895
0.454956
4
0
1
no
0.2
0.1
dnr after sadm
4
78
5.899414
71
15
36.5
93.32812
null
null
2
138
7.379883
null
null
null
null
1
<2 mo. follow-up
1
8,124
79.69897
1
male
0
7
71
COPD
COPD/CHF/Cirrhosis
5
null
null
0
9,814
8,019.625
7,759.37891
11
white
19.898438
34
0.735962
0.585938
1
0
0
yes
0.7
0.5
dnr after sadm
1
110
21.199219
118
28
35.59375
304.75
4.199219
0.399963
1.199951
139
7.459961
null
null
null
null
null
null
4.431641
8,125
51.27197
1
female
0
5
338
Colon Cancer
Cancer
1
12
$25-$50k
0
2,531
2,096.4453
1,889.21973
6
white
11.199219
11
0.897949
0.764893
1
0
0
metastatic
0.6
0.2
no dnr
5
75
null
89
22
36.19531
null
3.899902
0.299988
0.799927
136
null
null
null
null
0
0
no(M2 and SIP pres)
0
8,126
64.62695
1
female
0
8
1,531
COPD
COPD/CHF/Cirrhosis
2
12
null
0
5,192
4,223.6055
3,330.64844
13
white
16.097656
28
0.900879
0.833984
1
0
0
no
0.7
0.5
no dnr
8
63
11.699219
73
32
36.39844
200
4.199219
0.5
0.699951
134
7.299805
null
null
null
2
2
no(M2 and SIP pres)
2
8,127
70.21796
1
female
0
8
18
Coma
Coma
2
8
under $11k
44
9,225
7,920.3242
8,289.5625
13.5
white
17.398438
17
0.619995
0.557983
1
0
1
no
0.05
0.000125
dnr after sadm
2
115
6.399414
60
24
35.59375
null
3.399902
0.299988
0.899902
143
null
null
null
null
null
6
<2 mo. follow-up
6
8,128
76.22699
1
male
1
5
5
COPD
COPD/CHF/Cirrhosis
3
7
under $11k
9
7,085
4,792.3516
4,949.99609
26
white
17.5
23
0.819946
0.706909
1
0
0
no
0.2
0.1
dnr after sadm
5
85
13.599609
138
10
38.09375
170
4.299805
0.299988
1.199951
139
7.399414
null
null
null
null
4
<2 mo. follow-up
4
8,129
76.159
1
male
0
4
257
Lung Cancer
Cancer
2
8
$11-$25k
0
3,508
2,545.4492
2,052.04883
11
white
19
25
0.636963
0.327942
1
0
0
metastatic
0.9
0.5
no dnr
4
67
18.597656
66
24
36.29688
null
null
null
1
132
null
null
null
null
0
null
no(M2 and SIP pres)
0.4948
8,130
64.71698
1
male
0
5
38
CHF
COPD/CHF/Cirrhosis
2
11
>$50k
0
2,744
2,202.8066
1,636.71973
18
white
26.199219
33
0.782959
0.651978
1
0
0
no
null
null
dnr after sadm
1
67
10
57
24
36.09375
null
3.599609
1.799805
2.399902
129
null
null
null
null
0
null
<2 mo. follow-up
0.4948
8,131
83.474
0
male
0
8
1,622
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
4,876
4,143.4727
3,467.36914
7
white
18.097656
20
0.78894
0.661987
1
0
0
no
0.9
0.75
no dnr
8
106
10
69
24
35.39844
null
null
null
1.299805
140
null
null
null
null
0
0
no(M2 and SIP pres)
0
8,132
44.34799
1
female
0
7
118
Colon Cancer
Cancer
1
12
under $11k
0
58,947
62,907.3125
65,362.875
20
white
23.796875
18
0.755981
0.5
1
0
0
metastatic
0.49
0.39
dnr after sadm
6
101
5.5
132
20
38.19531
null
null
null
0.599976
128
null
null
null
null
1
0
adl>=4 (>=5 if sur)
0
8,133
57.36099
1
male
1
6
6
Coma
Coma
2
null
null
44
5,527
4,044.2441
4,410.9375
23
white
18.296875
19
0.634888
0.573975
1
0
0
yes
0.1
0.001
dnr after sadm
1
72
11.099609
101
24
38
null
null
null
1.399902
148
null
null
null
null
null
null
<2 mo. follow-up
2.000488
8,134
78.89899
1
female
0
9
807
Colon Cancer
Cancer
1
null
null
0
13,276
8,470.8203
4,400.08984
16.5
white
13.699219
18
0.834961
0.639893
1
0
0
metastatic
0.7
0.6
no dnr
9
68
7.299805
67
16
36.79688
null
3.599609
0.399963
0.699951
141
null
null
null
null
null
null
null
2.405762
8,135
60.76099
1
male
0
9
176
ARF/MOSF w/Sepsis
ARF/MOSF
3
20
null
26
10,343
8,276
6,551.45703
12.5
white
25.699219
44
0.718994
0.632935
1
0
0
no
0.95
0.8
no dnr
9
122
12.798828
108
28
36.29688
525.875
2.5
0.899902
11.5
132
7.419922
null
null
null
null
0
no(M2 and SIP pres)
0
8,136
58.54099
0
male
0
23
1,618
ARF/MOSF w/Sepsis
ARF/MOSF
1
null
null
9
43,636
37,861.7188
31,906.5312
17.333328
white
19.296875
34
0.777954
0.705933
11
0
0
yes
null
null
no dnr
23
103
34.398438
98
24
37.89844
219.96875
null
null
1.5
145
7.419922
null
null
null
null
null
null
1.980469
8,137
67.39996
1
male
1
7
7
COPD
COPD/CHF/Cirrhosis
6
20
under $11k
0
6,910
4,843.6016
4,028.19922
13.5
white
41.59375
46
0.311951
0.130981
1
0
0
yes
0.1
0.001
dnr after sadm
2
115
35.296875
114
32
36.09375
69.375
3.299805
0.699951
0.5
128
7.269531
null
null
null
null
3
<2 mo. follow-up
3
8,138
65.57397
1
female
1
8
8
Coma
Coma
4
12
under $11k
100
16,053
11,305.8203
11,408.7734
26.5
white
28.796875
28
0.046997
0.023998
8
1
1
no
0.1
0.001
no dnr
8
44
12.199219
78
8
38
170
2.699707
0.299988
0.899902
131
7.449219
null
null
null
null
4
<2 mo. follow-up
4
8,139
79.10199
1
female
0
24
37
Colon Cancer
Cancer
1
8
under $11k
0
12,781
11,217.625
9,313.01562
12.333328
white
17.097656
33
0.78894
0.554932
1
0
0
metastatic
null
null
dnr after sadm
1
107
8.798828
84
28
36.59375
342.8125
3.399902
0.599976
1.199951
134
7.469727
null
null
null
null
1
<2 mo. follow-up
1
8,140
68.383
1
male
0
9
64
CHF
COPD/CHF/Cirrhosis
5
8
$11-$25k
0
5,863
4,946.7148
4,396.44922
6
white
24.699219
47
0.789917
0.66394
1
0
0
no
0.8
0.5
dnr after sadm
1
53
13
70
24
36.79688
214.8125
4
0.799927
2.299805
130
7.419922
null
null
null
1
0
no(M2 and SIP pres)
0
8,141
78.95697
0
female
0
5
1,610
CHF
COPD/CHF/Cirrhosis
4
11
under $11k
0
4,206
3,423.6699
2,941.35938
15
white
20.699219
31
0.805908
0.68689
1
0
0
no
0.9
0.9
no dnr
5
54
5.599609
59
24
36.89844
null
3.299805
1
1.299805
142
null
null
null
null
0
0
no(M2 and SIP pres)
0
8,142
73.04596
1
female
0
21
77
Colon Cancer
Cancer
1
14
under $11k
37
10,583
9,048.7578
8,211.65625
7.333332
white
11.798828
17
0.781982
0.542969
1
0
0
metastatic
1
0.55
dnr after sadm
15
129
4.5
93
16
37.89844
null
3.799805
1.699951
1
134
null
null
null
null
null
1
no(M2 and SIP pres)
1
8,143
40.39697
1
male
1
23
23
MOSF w/Malig
ARF/MOSF
2
16
$25-$50k
0
82,155
101,362.375
95,366.9375
38.333313
white
34
68
0.35199
0.234985
53
0
0
yes
0.05
0.000125
no dnr
23
64
0.099991
146
34
40.09375
null
2.899902
2.5
1.199951
133
null
null
null
null
null
1
<2 mo. follow-up
1
8,144
42.133
1
female
1
75
75
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
26
262,140
178,584.375
151,271.625
42.5
white
30
31
0.652954
0.553955
9
0
0
no
0.9
0.9
dnr after sadm
74
103
15.5
120
12
39.69531
103.32812
2.399902
0.5
0.599976
137
7.479492
null
null
null
null
0
adl>=4 (>=5 if sur)
0
8,145
74.95697
1
male
0
4
52
Lung Cancer
Cancer
1
15
$25-$50k
9
3,143
2,138.3906
1,401.7793
10
white
13.099609
20
0.72998
0.457947
1
0
0
metastatic
0.9
0.7
no dnr
4
119
14.599609
87
20
36.09375
null
3.799805
0.299988
1.199951
138
null
null
null
null
null
null
<2 mo. follow-up
2.061523
8,146
73.04297
1
female
0
10
1,164
COPD
COPD/CHF/Cirrhosis
2
8
under $11k
0
8,504
6,603.0742
5,872.08984
17
white
17.796875
27
0.851929
0.755981
1
0
0
no
null
null
no dnr
10
107
19.296875
65
28
36
216
3.799805
0.599976
1.099854
138
7.389648
null
null
null
2
0
no(M2 and SIP pres)
0
8,147
80.78894
1
male
0
6
644
COPD
COPD/CHF/Cirrhosis
4
7
under $11k
0
3,369
2,766.6016
2,815.76953
14
white
21.699219
34
0.691895
0.526978
1
0
0
yes
0.5
0.1
no dnr
6
70
7
114
28
35.69531
460
null
0.799927
1.199951
138
7.339844
null
null
null
null
null
null
3.179199
8,148
78.02295
0
female
0
7
1,604
COPD
COPD/CHF/Cirrhosis
3
8
under $11k
0
5,563
4,325.4375
3,838.91992
9
white
14.798828
38
0.825928
0.716919
1
1
0
yes
null
null
no dnr
7
109
6.199219
76
28
36.79688
204.75
3
0.199982
0.599976
140
7.369141
null
null
null
2
4
no(M2 and SIP pres)
4
8,149
74.25598
1
female
0
16
111
Colon Cancer
Cancer
1
8
$11-$25k
0
7,361
6,515.6016
6,316.35938
7.666664
white
6.5
20
0.908936
0.789917
1
0
0
metastatic
0.8
0.5
dnr after sadm
16
104
7.299805
74
24
38
null
4
0.5
1.099854
136
null
null
null
null
null
0
no(M2 and SIP pres)
0
8,150
71.02295
1
female
0
4
170
COPD
COPD/CHF/Cirrhosis
1
null
null
0
1,851
1,514.1279
1,188
11
white
18.5
22
0.853882
0.758911
1
0
0
no
0.9
0.9
no dnr
4
107
null
98
28
36
452
null
null
null
140
7.379883
null
null
null
null
null
null
2.083496
8,151
68.44897
1
male
0
7
70
Colon Cancer
Cancer
1
null
null
0
3,947
3,385.7012
3,018.31836
6
white
16.296875
14
0.819946
0.611938
1
0
0
metastatic
null
null
no dnr
7
80
10
107
24
38.59375
null
3.599609
0.5
1
133
null
null
null
null
null
null
null
2.251465
8,152
64.698
0
male
0
4
1,600
CHF
COPD/CHF/Cirrhosis
2
14
$11-$25k
0
1,917
1,679.8438
1,222.37988
14
white
16.796875
16
0.892944
0.819946
1
0
0
no
0.9
0.8
no dnr
4
70
null
73
16
35.39844
null
null
null
1.199951
140
null
null
null
null
null
null
no(M2 and SIP pres)
1.821289
8,153
82.99799
1
male
1
4
4
CHF
COPD/CHF/Cirrhosis
7
null
null
0
2,277
1,776.459
1,493.75977
26
white
20.398438
39
0.746948
0.601929
1
1
1
yes
0.1
0.001
dnr after sadm
1
106
9.298828
60
40
37.89844
300
3.199707
0.899902
1.5
145
7.349609
null
null
null
null
null
<2 mo. follow-up
6.266602
8,154
54.79498
0
female
0
11
1,598
COPD
COPD/CHF/Cirrhosis
2
12
$25-$50k
0
10,684
7,769.9062
7,832.01953
19.5
white
18.398438
22
0.91394
0.85498
1
0
0
no
0.8
0.5
no dnr
11
110
12.099609
76
32
36.79688
193.3125
null
null
0.899902
140
7.379883
null
null
null
null
0
adl>=4 (>=5 if sur)
0
8,155
75.09399
1
male
0
10
60
Cirrhosis
COPD/CHF/Cirrhosis
2
8
under $11k
9
15,305
10,673.5938
8,756.25
33
white
24.699219
41
0.455994
0.253967
1
0
0
yes
0.5
0.25
dnr after sadm
1
117
12.199219
42
49
36.29688
null
3
2.699707
1.199951
136
null
null
null
null
null
0
no(M2 and SIP pres)
0
8,156
57.88098
0
female
0
39
1,596
ARF/MOSF w/Sepsis
ARF/MOSF
0
12
under $11k
0
66,800
45,979.0625
47,007.7188
37
white
36.398438
60
0.600952
0.493958
1
0
0
no
null
null
no dnr
39
49
7.599609
138
39
39.39844
195
2.899902
4.899414
1.599854
148
7.389648
null
null
null
null
1
null
1
8,157
72.56097
1
male
0
7
49
CHF
COPD/CHF/Cirrhosis
2
12
under $11k
0
3,628
3,037.8301
2,097.91992
6
white
26.097656
53
0.748901
0.603882
1
0
0
no
0.7
0.5
dnr after sadm
1
53
7.899414
74
28
34.69531
545.625
4
2.899902
1.899902
139
7.339844
null
null
null
null
5
<2 mo. follow-up
5
8,158
70.26398
1
female
0
9
22
Colon Cancer
Cancer
2
8
null
0
12,682
10,659.3516
11,444.0547
13.5
white
17
14
0.807983
0.588989
1
0
0
metastatic
0.75
0.25
no dnr
9
60
12.898438
77
20
38.69531
null
3.299805
0.199982
0.799927
134
null
null
null
null
null
6
<2 mo. follow-up
6
8,159
70.66095
1
female
0
15
1,269
MOSF w/Malig
ARF/MOSF
1
16
null
9
15,128
11,270.9531
10,102.7734
16.666656
white
25.597656
36
0.497986
0.380981
3
0
0
metastatic
null
null
no dnr
15
142
5.899414
138
16
36
452
3.899902
0.5
1.899902
142
7.369141
null
null
null
null
1
no(M2 and SIP pres)
1
8,160
74.97595
0
male
0
22
1,590
Coma
Coma
0
14
>$50k
0
44,963
32,121.5469
28,611.6094
31.666656
white
18.199219
15
0.73291
0.68396
1
0
0
no
0.99
0.9
no dnr
22
117
7.199219
66
24
36.79688
163
4.399414
0.599976
0.899902
138
7.429688
null
null
null
0
0
no(M2 and SIP pres)
0
8,161
61.61499
1
female
0
3
5
Lung Cancer
Cancer
1
13
null
0
2,784
2,036.6143
1,695.25977
3
white
15.798828
10
0.738892
0.471985
1
0
0
metastatic
0.95
0.6
no dnr
3
100
null
93
20
36.19531
null
null
null
null
140
null
null
null
null
null
null
<2 mo. follow-up
1.985352
8,162
66.97894
1
male
0
5
528
Lung Cancer
Cancer
2
15
under $11k
0
3,928
3,099.3711
2,706.92969
7
white
8.699219
19
0.835938
0.640991
1
1
0
metastatic
0.8
0.6
no dnr
5
111
8
72
20
35.19531
null
4.299805
0.599976
1.099854
134
null
null
null
null
null
1
no(M2 and SIP pres)
1
8,163
53.91599
0
female
0
17
1,588
Coma
Coma
1
11
$11-$25k
0
24,481
16,262.6328
22,232.1719
22.333328
white
19
12
0.767944
0.723999
3
0
0
yes
0.8
0.8
dnr after sadm
1
119
16.296875
42
10
38.39844
262.5
4.199219
0.599976
0.799927
143
7.489258
null
null
null
null
0
adl>=4 (>=5 if sur)
0
8,164
47.07498
1
female
0
57
119
COPD
COPD/CHF/Cirrhosis
3
null
null
44
82,385
56,124.2812
56,664.5938
32
white
25.398438
24
0.691895
0.526978
1
0
0
metastatic
0.3
0.3
no dnr
57
75
12.699219
127
8
38.79688
116
3.599609
0.399963
0.899902
141
7.169922
null
null
null
null
null
null
4.09668
8,165
89.54095
1
female
1
4
4
Coma
Coma
0
14
null
100
4,136
3,253.3594
2,923.5293
22
white
31.699219
67
0.003
0.001
1
0
0
no
0.05
0.000125
dnr after sadm
3
58
9.099609
110
40
38.5
140.8125
4.5
0.799927
3
143
7.169922
null
null
null
null
1
<2 mo. follow-up
1
8,166
91.34595
1
male
1
7
7
ARF/MOSF w/Sepsis
ARF/MOSF
1
8
under $11k
0
20,829
13,574.1875
13,898.7656
41
white
40.398438
57
0.213989
0.117996
3
0
1
no
0.3
0.3
dnr after sadm
7
47
15.599609
160
9
39.69531
123.32812
2.599609
1.399902
1.699951
133
7.429688
null
null
null
null
2
<2 mo. follow-up
2
8,167
88.79895
1
male
1
5
5
Coma
Coma
1
6
under $11k
100
2,583
2,126.9863
1,623.67969
12
white
19.796875
40
0.112
0.067993
1
0
0
no
null
null
no dnr
5
61
8.199219
66
10
38.79688
352.375
4.099609
1.699951
2
138
7.429688
null
null
null
null
3
<2 mo. follow-up
3
8,168
78.02295
1
female
1
10
10
ARF/MOSF w/Sepsis
ARF/MOSF
2
15
$11-$25k
0
33,443
21,901.5781
21,580.6875
31
white
34.09375
48
0.340942
0.224976
12
0
0
yes
0.25
0.25
no dnr
10
107
0.399963
120
26
36.39844
268
null
null
0.599976
131
7.479492
null
null
null
null
0
<2 mo. follow-up
0
8,169
82.31299
1
male
0
3
4
Coma
Coma
0
8
under $11k
100
6,698
4,614.625
4,624.59766
57
white
47
51
0
0
1
0
0
no
null
null
dnr after sadm
1
42
15.099609
114
20
35.89844
12
3
0.599976
1.399902
145
7.389648
null
null
null
null
0
<2 mo. follow-up
0
8,170
63.12097
1
male
0
5
89
Lung Cancer
Cancer
2
null
null
0
4,309
3,033.959
3,010.70898
11
white
11
16
0.81189
0.596924
1
0
0
metastatic
0.7
0.5
no dnr
5
103
5.5
104
22
36.29688
null
4.199219
0.699951
0.799927
134
null
null
null
null
null
null
null
1.967285
8,171
75.88995
1
male
0
7
58
COPD
COPD/CHF/Cirrhosis
3
12
$11-$25k
26
4,709
3,727.0742
3,350.64844
11
white
24.699219
47
0.636963
0.454956
1
1
1
no
0.8
0.7
dnr after sadm
1
69
11.599609
104
24
35.5
157.125
3.899902
0.599976
1.599854
135
7.369141
null
null
null
null
3
adl>=4 (>=5 if sur)
3
8,172
75.87695
1
male
0
7
977
CHF
COPD/CHF/Cirrhosis
2
13
$25-$50k
0
4,041
3,294.3086
2,848.53906
17
white
15
35
0.881958
0.802979
1
0
0
no
0.8
0.7
dnr after sadm
1
63
9.898438
73
28
35.79688
295.1875
3.899902
0.799927
1.099854
140
7.399414
null
null
null
0
0
no(M2 and SIP pres)
0
8,173
64.45996
1
female
0
12
1,179
COPD
COPD/CHF/Cirrhosis
3
9
under $11k
0
10,293
7,336.9844
7,129.15625
11.5
white
19.398438
20
0.840942
0.738892
1
0
0
yes
0.75
0.75
no dnr
12
87
34.398438
132
24
38.29688
285.125
4.099609
0.799927
0.699951
134
7.419922
null
null
null
null
2
no(M2 and SIP pres)
2
8,174
60.42999
1
female
0
5
1,513
Lung Cancer
Cancer
1
12
null
0
3,457
2,783.0488
2,312.45898
15
white
7.599609
11
0.85791
0.68396
1
0
0
metastatic
null
null
no dnr
5
72
3.5
70
20
36.19531
null
4.199219
0.399963
0.799927
136
null
null
null
null
null
null
no(M2 and SIP pres)
1.710938
8,175
67.16498
1
male
0
8
898
COPD
COPD/CHF/Cirrhosis
3
12
null
0
5,430
4,154.957
3,476.1582
8
white
24.097656
36
0.757935
0.615967
1
0
0
yes
0.9
0.9
no dnr
8
101
21
120
24
35.69531
209.0625
null
null
1.099854
138
7.40918
null
null
null
null
0
no(M2 and SIP pres)
0
8,176
52.95798
1
male
0
5
686
Lung Cancer
Cancer
2
9
under $11k
0
2,227
1,943.7852
1,477.59961
10
white
14.798828
16
0.773926
0.529907
1
0
0
metastatic
1
1
no dnr
5
107
7.799805
77
24
36.79688
null
null
null
1.399902
136
null
null
null
null
null
1
no(M2 and SIP pres)
1
8,177
82.57898
0
female
0
6
1,572
CHF
COPD/CHF/Cirrhosis
4
16
null
0
2,881
2,437.209
1,677.16992
10
white
20.398438
23
0.748901
0.60498
1
1
0
yes
1
1
no dnr
6
106
10.599609
54
24
35.59375
342.8125
null
null
1.199951
135
7.459961
null
null
null
0
0
no(M2 and SIP pres)
0
8,178
54.883
1
male
0
6
296
CHF
COPD/CHF/Cirrhosis
3
14
under $11k
0
15,018
10,734.4688
10,703.6641
19
white
22.898438
40
0.859985
0.768921
1
0
0
no
null
null
no dnr
6
58
8.699219
50
22
36.39844
null
4.099609
0.599976
2.599609
130
null
null
null
null
2
0
no(M2 and SIP pres)
0
8,179
70.57098
1
male
0
6
254
Lung Cancer
Cancer
2
7
under $11k
0
3,154
2,479.1641
2,328.84961
6
white
3.099609
23
0.888916
0.746948
1
0
0
metastatic
0.6
0.3
no dnr
6
69
6
81
24
36.59375
null
4.399414
0.399963
1.099854
142
null
null
null
null
null
null
no(M2 and SIP pres)
1.677246
8,180
82.06696
1
male
0
6
356
Lung Cancer
Cancer
2
8
null
0
3,685
3,021.3086
2,684.58984
8
white
14.099609
26
0.725952
0.451965
1
0
0
metastatic
0.5
0.3
no dnr
6
77
6.099609
77
22
35.59375
null
3.699707
0.399963
1.099854
134
null
null
null
null
0
null
null
0.4948
8,181
68.17798
1
male
0
6
101
Colon Cancer
Cancer
3
12
$25-$50k
0
3,745
2,759.084
2,308.72852
10
white
18.199219
13
0.793945
0.564941
1
1
0
metastatic
0.8
0.5
no dnr
6
92
null
56
20
35.59375
null
null
null
null
140
null
null
null
null
0
1
null
1
8,182
84.03796
0
female
0
8
1,566
COPD
COPD/CHF/Cirrhosis
5
12
null
0
5,013
3,908.5117
3,510.07812
14.5
white
15.5
41
0.822998
0.711914
1
0
0
no
0.5
0.25
dnr after sadm
1
59
11.898438
69
26
36.19531
268
3.899902
0.299988
1
137
7.379883
null
null
null
null
4
no(M2 and SIP pres)
4
8,183
66.31299
0
male
0
7
1,566
CHF
COPD/CHF/Cirrhosis
1
12
$11-$25k
0
14,233
11,140.5781
9,157.45312
13
white
21.199219
19
0.800903
0.678955
9
0
0
no
null
null
no dnr
7
62
null
105
20
38
145
null
null
1.199951
135
7.429688
null
null
null
0
3
no(M2 and SIP pres)
3
8,184
58.883
1
male
1
4
4
Coma
Coma
0
6
$11-$25k
100
10,109
6,643.3828
7,060.84766
27
white
27.097656
45
0.182983
0.125977
1
0
0
no
0.01
0.000001
dnr after sadm
1
167
15.599609
182
8
39
164
4.599609
0.399963
0.799927
155
7.569336
null
null
null
null
1
<2 mo. follow-up
1
8,185
81.88397
1
female
0
4
1,045
CHF
COPD/CHF/Cirrhosis
2
6
null
0
2,367
1,813.1553
1,324.67969
6
hispanic
16.699219
35
0.846924
0.748901
1
0
0
no
0.7
0.7
no dnr
4
61
4.599609
80
28
36
252.375
null
null
1.099854
136
7.519531
null
null
null
null
null
no(M2 and SIP pres)
2.143066
8,186
70.034
0
male
0
32
1,566
Coma
Coma
0
16
>$50k
44
36,490
25,928.2812
25,123.3438
18.5
white
23
18
0.471985
0.399963
1
0
0
no
null
null
no dnr
32
133
18.796875
106
10
38.09375
140
null
null
1
143
7.529297
null
null
null
null
0
adl>=4 (>=5 if sur)
0
8,187
45.06497
0
female
0
12
1,564
CHF
COPD/CHF/Cirrhosis
2
12
null
0
9,426
7,679.543
6,140.44922
9
white
17.898438
17
0.922974
0.868896
1
0
0
no
null
null
no dnr
12
74
10.5
126
20
35.59375
null
4.299805
1.299805
1.099854
139
null
null
null
null
0
null
null
0.4948
8,188
81.85394
1
male
0
13
1,083
CHF
COPD/CHF/Cirrhosis
5
8
$11-$25k
0
6,725
5,676.6602
4,296.05859
7.5
white
17.398438
32
0.838989
0.736938
1
0
0
no
0.7
0.6
no dnr
13
112
7.899414
76
20
36.19531
238.09375
3.699707
0.799927
1.799805
133
7.509766
null
null
null
5
5
SIP>=30
5
8,189
61.71399
1
female
0
41
65
Coma
Coma
0
12
null
61
57,452
48,214.875
45,286.1875
30.25
white
16.796875
21
0.632935
0.571899
1
0
0
no
1
0.99
no dnr
41
123
19.296875
68
8
38
210
4.799805
0.899902
1.099854
147
7.439453
null
null
null
null
0
null
0
8,190
71.461
0
female
0
42
1,562
ARF/MOSF w/Sepsis
ARF/MOSF
4
8
null
0
43,218
32,969
26,999.2969
18.75
white
33.59375
59
0.509888
0.392944
1
1
0
yes
0.8
0.8
no dnr
42
68
28
134
28
35.19531
null
3.199707
0.5
5.899414
132
null
null
null
null
null
5
no(M2 and SIP pres)
5
8,191
80.84094
0
female
0
13
1,563
CHF
COPD/CHF/Cirrhosis
3
null
null
0
17,250
12,146.3047
10,440.8125
19.5
white
16.597656
23
0.851929
0.755981
1
0
0
no
0.75
0.5
no dnr
13
63
6
52
20
36.69531
null
null
null
1.199951
141
null
null
null
null
null
null
null
3.058594
8,192
71.58099
0
male
0
3
1,560
Lung Cancer
Cancer
1
9
$11-$25k
0
1,985
1,450.2559
1,251.7793
7
white
16
20
0.711914
0.430969
1
0
0
metastatic
0.9
0.8
no dnr
3
117
5.5
62
24
36.09375
null
3.599609
0.5
1.5
139
null
null
null
null
null
null
no(M2 and SIP pres)
2.019043
8,193
59.49298
1
male
0
5
59
Lung Cancer
Cancer
1
12
$25-$50k
0
2,963
2,366.2129
1,990.06934
9
white
24.898438
19
0.53894
0.215973
1
0
0
metastatic
0.2
0.1
dnr after sadm
1
73
40
101
20
36
338.0625
null
0.599976
0.799927
130
7.40918
null
null
null
1
3
no(M2 and SIP pres)
3
8,194
74.55695
0
male
0
3
1,560
COPD
COPD/CHF/Cirrhosis
3
11
null
0
2,100
1,671.5469
1,479.7793
18
white
9.898438
26
0.914917
0.855957
1
0
0
no
0.8
0.8
no dnr
3
71
9.298828
60
20
36.19531
376.1875
4.799805
0.5
1.299805
141
7.459961
null
null
null
null
null
null
2.165039
8,195
70.11096
1
male
1
10
10
COPD
COPD/CHF/Cirrhosis
1
null
null
0
10,505
7,555.5586
6,805.32812
26.5
white
19.398438
45
0.8479
0.75
1
0
0
no
0.9
0.75
dnr after sadm
9
105
36.398438
110
36
38.29688
242.84375
4
0.399963
1.399902
136
7.5
null
null
null
null
null
<2 mo. follow-up
2.825684
8,196
58.71899
0
male
0
343
1,558
ARF/MOSF w/Sepsis
ARF/MOSF
0
18
$25-$50k
0
556,878
463,230
409,602
47.75
white
45.695313
66
0.221985
0.123993
13
0
0
no
null
null
dnr after sadm
45
53
20.699219
124
34
39.19531
62.10156
null
null
4.399414
153
7.25
null
null
null
null
1
adl>=4 (>=5 if sur)
1
8,197
63.16498
1
female
0
6
556
Lung Cancer
Cancer
1
12
$11-$25k
0
2,532
2,167.4883
1,894.41992
9
white
19.5
21
0.660889
0.358948
1
0
0
metastatic
0.9
0.5
no dnr
6
73
2
107
16
37.89844
null
null
null
1
129
null
null
null
null
null
null
no(M2 and SIP pres)
2.09668
8,198
79.77496
0
male
0
5
1,555
COPD
COPD/CHF/Cirrhosis
2
null
null
0
3,239
2,465.4785
2,160.48828
16
white
16.296875
27
0.835938
0.731934
1
0
0
no
0.99
0.8
no dnr
5
93
7.399414
71
22
36.09375
190.46875
3.599609
0.299988
1.199951
137
7.439453
null
null
null
null
null
null
2.457031
8,199
63.48297
1
male
0
116
618
ARF/MOSF w/Sepsis
ARF/MOSF
3
12
null
37
101,761
154,723.125
129,909.062
27.5
white
36
47
0.287964
0.177979
10
1
0
no
0.8
0.9
no dnr
116
100
15.199219
116
12
39.69531
212.5
3.399902
7.699219
4.199219
150
7.399414
null
null
null
null
0
adl>=4 (>=5 if sur)
0
8,200
88.11499
1
male
0
11
1,347
COPD
COPD/CHF/Cirrhosis
1
5
null
0
7,987
6,105.9609
4,972.75
14
white
21.097656
36
0.702881
0.539917
1
0
0
no
0.5
0.5
dnr after sadm
1
105
11.298828
100
36
36.19531
159.15625
4.399414
0.399963
1.699951
142
7.449219
null
null
null
null
0
no(M2 and SIP pres)
0